Database

Cellink

Introduction
the life science venture capAs the leading 3D bioprinting company, CELLINK is committed to providing the most advanced 3D bioprinting products, services and technologies needed to understand and master biology. We develop technologies that democratize 3D bioprinting – providing the leading researchers in the world the tools they need to create the future of health. Whether it is developing and utilizing alternatives to animal models, accelerating drug discovery, rethinking regenerative medicine or developing tissue engineered organs to treat diseases previously considered untreatable.ital industry and the technology transfer field.




more ↓
Country
Sweden
Founded Year
1899
Unified Business No.
瑞典商
Status
Active
Total Paid-in Capital
0 (NT$)
Investors Type
Strategic CVCs、Foreign Investors
Funding Rounds
Pre-Seed
NDF Collaborated Investor
No

More Similar Investors

:::
回頁面最頂端